Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2001; 85(03): 574-576
DOI: 10.1055/s-0037-1615632
DOI: 10.1055/s-0037-1615632
Letters to the Editor
Acute Local Release of Fibroblast Growth Factor-2 but not Transforming Growth Factor-β1 following Coronary Stenting
Authors
Further Information
Publication History
Received
11 September 2000
Accepted after revision
16 October 2000
Publication Date:
08 December 2017 (online)
-
References
- 1 Falciani M, Gori AM, Giusti B, Fedi S, Capanni M, Simonetti I, Margheri M, Prisco D, Abbate R, Gensini GF. Percutaneous Transluminal Coronary Angioplasty procedure is associated to a decrease in transforming growth factor beta 1 levels. Thromb Haemost 1999; 82: 1204-5.
- 2 Brogi E, Winkles JA, Underwood R, Clinton SK, Alberts GF, Libby P. Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. J Clin Invest 1993; 92: 2408-18.
- 3 Rasmussen LM, Wolf YG, Ruoslahti E. Vascular smooth muscle cells from injured rat aortas display elevated matrix production associated with transforming growth factor-beta activity. Am J Path 1995; 147: 1041-8.
- 4 Libby P, Tanaka H. The molecular bases of restenosis. Prog Cardio Dis 1997; 40: 97-106.
- 5 McCaffrey TA, Du B, Fu C, Bray PJ, Sanborn T, Deutsch E, Tarazona N, Shaknovitch A, Newman G, Patterson C, Bush HL. The expression of TGF B, receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance. J Mol Cell Card 1999; 31: 1627-42.
- 6 Taylor AJ, Farb AA, Angello DA, Burwell LR, Virmani R. Proliferative activity in coronary atherectomy tissue. Clinical, histopathologic and immunohistochemical correlates. Chest 1995; 108: 815-20.
- 7 Caplice NM, Aroney CN, Bett JHN, Cameron J, Campbell JH, Hoffman N, McEniery PT, West MJ. Growth factors released into the coronary circulation after vascular injury promote proliferation of human vascular smooth muscle cells in culture. J Am Coll Cardiol 1997; 29: 1536-41.
- 8 Hasdai D, Holmes DR, Garrett KN, Edwards WD, Lerman A. Mechanical pressure and stretch release endothelin 1 from human athersclerotic coronary arteries in vivo. Circ 1997; 95: 357-62.
- 9 Lowe HC, Murray B, Chong BH, Chesterman CN, Khachigian LM. Intra-coronary blood sampling using the multifunction probing catheter does not cause platelet activation. J Invas Cardiol 2000; 12: 144-6.
- 10 Chong BH, Murray B, Berndt MC, Dunlop LC, Brighton T, Chesterman CN. Plasma P-selectin is increased in thrombotic consumptive platelet disorders. Blood 1994; 83: 1535-41.
- 11 Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. PNAS 1991; 88: 3739-43.
- 12 Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA. Role of basic fibro-blast growth factor in vascular lesion formation. Circ Res 1991; 68: 106-13.
- 13 Kahn JK. Coronary stents: increasing options and indications. Cathet Cardiovasc Diagn 1998; 45: 375.